NATCO Pharma Limited

NSE:NATCOPHARM.NS

1515.05 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q3
Assets:
Current Assets:
Cash & Cash Equivalents 9,529-12,1561,040-11,6211,319-10,0461,081-7,9991,111-7,732698-8,548258-10,9962,062-9,535198-10,347148-10,576283-13,644242-8,663217-1,397113-679235-612.8238.1-660.8440.658-966.6765.4-134.8124.416-100.399.8-113.7102.155-153.4145.3-134.629118.204-243.8233.7366.312
Short Term Investments 4,43524,31211,11623,24210,30220,0928,96515,9986,48815,4647,03417,0967,84421,9928,93419,0708,82720,69410,19921,15210,29327,28813,40217,3268,2462,7941,2841,3581,1371,225.61,146.91,321.6209.6421,933.2201.2269.61.183200.60.5227.43.18306.88.1269.2598.122487.610.17.375
Cash and Short Term Investments 13,96412,15612,15611,62111,62110,04610,0467,9997,5997,7327,7328,5488,10210,99610,9969,5359,02510,34710,34710,57610,57613,64413,6448,6638,4631,3971,3976791,372612.81,385660.8650.3966.6966.6134.8125.599100.3100.3113.7105.335153.4153.4134.629126.326243.8243.8373.687
Net Receivables 11,979011,28708,66303,81406,71004,76004,70606,50505,51305,67206,85604,67607,16603,42705,27303,09803,698.69503,049.302,150.71402,480.501,460.9702,084.501,449.41402,106946.902
Inventory 7,00507,09807,42907,49307,62009,14107,98206,71305,58005,15705,29004,77504,38403,86103,48904,233.503,572.83202,742.302,199.99701,77801,811.24701,506.901,460.2401,252.71,103.893
Other Current Assets 7,28702,95602,29002,67403,04303,61302,58302,90808,65102,443075001,92301,29401,149073901,032.90401.21052.70353.3520103.70303.813049.60293.598023.3712.132
Total Current Assets 40,23512,15633,49711,62130,00310,04624,0277,99924,9727,73225,2468,54823,37310,99627,1229,53523,25610,34723,61910,57623,47213,64425,0188,66321,3071,3979,83467910,873612.89,749.4660.88,323.038966.66,810.9134.84,829.663100.34,462.5113.73,681.364153.43,794.4134.6293,329.577243.83,625.83,136.615
Non-Current Assets:
Property, Plant & Equipment, Net 24,350023,531023,034023,326023,084022,712022,372021,292020,937019,872018,561016,750014,927013,030011,63509,859.909,164.02808,343.607,929.88707,458.707,365.14306,485.506,597.47704,953.94,653.35
Goodwill 56005580552050705070000000000000000000000036.939000410.263000255.995000238.72900168.394
Intangible Assets 1,37101,42601,32601,404082201170940950880860870750118055058054.2052.2520450.6049.1980503.9064.0580258.6049.6870178.4162.183
Goodwill and Intangible Assets 1,93101,98401,87801,91101,32901170940950880860870750118055058054.2089.1910450.60459.4610503.90320.0530258.60288.4160178.4162.183
Long Term Investments 1,3980-8,5660-9,2590-7,5700-5,6510-5,0140-6,2500-7,1010-7,9910-9,8550-10,0940-13,0450-8,1650-1,1230-1,1360-1,069.90-123.7890-185.50110.867015.2082.2290774.9095.7890774.8610.508
Tax Assets 194015209,259000007,04808,04509,09709,589010,219010,988013,40209,02301,28401,62101,2160779.2320923.40502.2570552.90501.9320-258.60491.60-178.47.375
Other Non-Current Assets 955-12,15611,942-11,6211,659-10,0469,085-7,9997,357-7,732408-8,548285-10,996554-9,535-1-10,347679-10,57617-13,644690-8,663-59-1,397661-679125-612.8895.4-660.86.343-966.699.8-134.88.314-100.337.8-113.76.373-153.41,460.8-134.6291.26501,004.4457.735
Total Non-Current Assets 28,828-12,15629,043-11,62126,571-10,04626,752-7,99926,119-7,73225,271-8,54824,546-10,99623,937-9,53522,622-10,34721,001-10,57619,559-13,64417,872-8,66315,844-1,39713,907-67912,303-612.810,955.6-660.89,915.005-966.69,631.9-134.89,010.787-100.38,568.5-113.78,275.73-153.48,721.2-134.6297,474.54706,733.15,891.151
Total Assets 69,063062,540056,574050,779051,091050,517047,919051,059045,878044,620043,031042,890037,151023,741023,176020,705018,238.043016,442.8013,840.45013,031011,957.094012,515.5010,804.124010,358.99,027.765
Liabilities & Equity:
Current Liabilities:
Account Payables 2,35503,66102,63801,43301,61801,53101,46202,93202,55401,52702,17002,54904802,22002003,502.3025.55401,702.501,253.0140982.401,097.86301,070.301,022.57101,050.9923.564
Short Term Debt 3,65902,41301,656084704,24003,61702,83004,32803,28503,01403,86302,21001,73201,94702,21601,60301,125.1601,088.402,161.99501,459.501,459.57701,697.901,477.43501,237.7816.422
Tax Payables 323067301010200904201305010850920660197026057013300034000200000000000
Deferred Revenue 32301,97008620003004201301,452088401,30001,12701,13504,014082903,9160675.203,202.486011.60332.17409.30275.94803.30131.008011.56.605
Other Current Liabilities 3,391073901,67501,72701,21601,3930951015801300857012702,1960126021801130473.30575.8090912.50390.2201,212.10289.43301,076.80817.68801,002.5819.093
Total Current Liabilities 9,72808,78306,83104,00707,10406,58305,25608,87006,85306,69807,28708,09005,92005,21406,26506,253.804,929.00803,71504,137.40303,663.303,122.82103,848.303,448.70103,302.62,565.684
Non-Current Liabilities:
Long Term Debt 53062011090800940909090000000000000000035.90970.1570771.30954.86301,317.101,378.25501,389.91,340.987
Deferred Revenue Non-Current 000017000130001100080008000800080007.710115.208.2570118010.3990161.406.910115.297.781
Deferred Tax Liabilities Non-Current 2046012402160301049404130328025901080116013401390152015002020144.1540136.10118.8940419.80430.5660431.60443.2540305.4288.94
Other Non-Current Liabilities 74907140-41,7830834095701,059099601,06009020924071004650324026302190194.40124.70907.7094.976012.60110.8890655.1086.207013.213.536
Total Non-Current Liabilities 80408220-41,63101,05901,35101,64701,42901,39701,17801,032083405990471041503770396.40276.5740294.901,192.28501,321.701,506.71702,565.201,914.62701,823.71,741.243
Total Liabilities 10,53209,6050-34,80005,06608,45508,23006,685010,26708,03107,73008,12108,68906,39105,62906,64206,650.205,205.58204,009.905,329.68904,98504,629.53806,413.505,363.32805,126.34,306.928
Equity:
Preferred Stock 000000000000000000000000000000000000000000000000
Common Stock 358035803650365036503650365036403640364036503690369034903490348.30348.3480348.30332.3480330.70330.7310681.80313.7310311.5311.48
Retained Earnings 44,65700032,92300026,66600025,68200022,39100019,57500014,2390009,0940005,663.7520004,673.9950003,638.0350002,914.161002,421.321
Accumulated Other Comprehensive Income/Loss 58,17352,93552,57748,7381,38545,71345,34842,6361,52742,28741,92241,21614,28040,65740,29337,735-5,50436,85036,48634,890-4,57634,17133,80230,722-3,80018,10417,75516,493-3,18414,009.113,660.812,983.3-2,677.88412,383.112,034.88,460.5-2,216.3377,925.57,594.87,258.7-1,682.886,147.95,834.25,335.429-1,389.19900-1,163.809
Other Total Stockholders Equity -44,65700014,06500014,0780018889135011220,4844002019,5263003819,914804110,23445.7049.19,649.12149.8050.35,670.505120.5068.84,972.8750-414105.3673,496.73604,903.93,143.007
Total Shareholders Equity 58,53152,93552,93548,73848,73845,71345,71342,63642,63642,28742,28741,23441,21640,79240,65737,84737,73536,89036,85034,91034,89034,20134,17130,76030,72218,11218,10416,53416,49314,054.814,009.113,032.412,983.33812,432.912,383.18,510.88,460.5118,0467,925.57,327.57,258.766,147.96,1025,440.7965,335.4295,232.65,215.44,711.998
Total Equity 58,53152,93552,93548,73891,37445,71345,71342,63642,63642,28742,28741,23441,23440,79240,79237,84737,84736,89036,89034,91034,91034,20134,20130,76030,76018,11218,11216,53416,53414,054.814,054.813,032.413,032.46112,432.912,432.98,510.88,510.7618,0468,0467,327.57,327.5566,147.96,1025,440.7965,440.7965,232.65,232.64,720.837
Total Liabilities & Shareholders Equity 69,06352,93562,54048,73856,57445,71350,77942,63651,09142,28750,51741,23447,91940,79251,05937,84745,87836,89044,62034,91043,03134,20142,89030,76037,15118,11223,74116,53423,17614,054.820,70513,032.418,238.04312,432.916,442.88,510.813,840.458,04613,0317,327.511,957.0946,147.912,515.55,440.79610,804.124010,358.99,027.765